or Try an Advanced Search...

    Genetic Diseases Stocks List

    Symbol Grade Name % Change
    ADVM F Adverum Biotechnologies, Inc. -4.05
    INZY F Inozyme Pharma, Inc. -2.69
    CODX F Co-Diagnostics, Inc. 0.96
    BMRN F BioMarin Pharmaceutical Inc. 0.87
    BDTX F Black Diamond Therapeutics, Inc. -1.65
    SYBX F Synlogic, Inc. -3.79
    LRMR D Larimar Therapeutics, Inc. 0.33
    STOK D Stoke Therapeutics, Inc. 0.88
    BPMC C Blueprint Medicines Corporation 2.21
    KRYS C Krystal Biotech, Inc. 1.76
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Biotechnology Disease Rare Genetic Disease Cancer Rare Genetic Diseases Biopharmaceutical Medicine Rare Diseases Biology Clinical Medicine Drug Discovery Gene Therapy Inborn Errors Of Metabolism Intellectual Disability Phenylketonuria Pku Tyrosine Kinase Receptors Achondroplasia Acid Adverum Biotechnologies

    Related ETFs - A few ETFs which own one or more of the above listed Genetic Diseases stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 10.23
    HELX D Franklin Genomic Advancements ETF 9.54
    XBI D SPDR S&P Biotech ETF 8.42
    GNOM F Global X Genomics & Biotechnology ETF 8.12
    WDNA D WisdomTree BioRevolution Fund 7.52
    View all Genetic Diseases ETFs...
    Compare ETFs
    Compare HELX to WDNA Compare PBE to HELX Compare PBE to XBI

        Genetic Diseases Stocks Recent News

        Date Stock Title
        Nov 20 ADVM Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
        Nov 20 STOK Stoke Therapeutics (STOK) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
        Nov 19 BMRN BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
        Nov 18 ADVM Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients
        Nov 18 ADVM Adverum Reports Positive Ixo-vec Data for Wet Age-Related Macular Degeneration; Shares Rise Pre-Bell
        Nov 18 LRMR Larimar Therapeutics Presents Additional Data from Phase 1 Studies and Phase 2 Dose Exploration Study Supporting the Nomlabofusp Clinical Program at ICAR 2024
        Nov 18 ADVM Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
        Nov 16 BMRN BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024
        Nov 15 BPMC Blueprint Medicines' Growth With AYVAKIT And Next-Gen Oncology Drugs
        Nov 15 ADVM Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
        Nov 15 SYBX Synlogic Third Quarter 2024 Earnings: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023)
        Nov 14 BPMC Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Biotechnology Cancer Medicine Biopharmaceutical Clinical Medicine Disease Rare Diseases Rare Genetic Disease Rare Genetic Diseases Acid Drug Discovery Inborn Errors Of Metabolism Intellectual Disability Medical Test Phenylketonuria Pku Severe Genetic Diseases Tyrosine Kinase Receptors Achondroplasia Applied Genetics
        Genetic Diseases

        Genetic diseases are disorders caused by changes in genes or chromosomes. These changes can be inherited from a parent or acquired during a person's lifetime. Examples of genetic diseases include cystic fibrosis, sickle cell anemia, and Huntington's disease.

        Browse All Tags